Key Technical Research on the Treatment of Post-stroke Cognitive Impairment With Brain Electric Field Therapy Based on Acupoint Regulation
1 other identifier
interventional
110
0 countries
N/A
Brief Summary
This clinical study investigates whether electroacupuncture can improve thinking and memory in people with cognitive problems after a stroke (Post-Stroke Cognitive Impairment, or PSCI). Participants will be randomly assigned to one of two groups: one group will receive real electroacupuncture, while the other will receive a sham treatment . Both groups will also receive standard medical care.The main goal is to see if the real electroacupuncture leads to greater improvement in cognitive function tests over 6 months compared to the sham treatment. The study will also use brain scans (MRI) and other assessments to understand how the treatment might work.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Feb 2026
Typical duration for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 9, 2026
CompletedStudy Start
First participant enrolled
February 10, 2026
CompletedFirst Posted
Study publicly available on registry
February 20, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2027
February 20, 2026
November 1, 2025
1.9 years
February 9, 2026
February 14, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Change in Mini-Mental State Examination (MMSE) Score
The Mini-Mental State Examination (MMSE) is a standardized 30-point questionnaire used to screen for cognitive impairment. Total scores range from 0 to 30, with higher scores indicating better cognitive function.
baseline, 3 months and 6 months post-treatment.
Change in MoCA (Montreal Cognitive Assessment) Scale Score
The Montreal Cognitive Assessment (MoCA) is a 30-point screening tool designed to detect mild cognitive impairment. Total scores range from 0 to 30, with higher scores indicating better cognitive function.
baseline, 3 months and 6 months post-treatment.
Change in Clinical Dementia Rating (CDR) scale Score
The Clinical Dementia Rating (CDR) is a clinician-rated scale that assesses the severity of dementia across six domains. The global CDR score ranges from 0 (no impairment) to 3 (severe dementia), with higher scores indicating greater severity of dementia.
baseline, 3 months and 6 months post-treatment.
Change in NTB (Neuropsychological Test Battery) Score
The Neuropsychological Test Battery (NTB) is a composite measure designed to assess cognitive function across multiple domains. It evaluates key areas including memory (e.g., verbal/visual recall), attention, executive function, and processing speed. A composite Z-score is derived by averaging the standardized scores of the individual cognitive tests. The composite score is interpreted such that higher scores indicate better overall cognitive performance.
baseline, 3 months and 6 months post-treatment.
Secondary Outcomes (8)
Multimodal functional Near-Infrared Spectroscopy - Electroencephalogram (fNIRS-EEG) Assessment
baseline, 3 months, and 6 month
Quality of Life as assessed by the Stroke-Specific Quality of Life Scale (SS-QOL)
baseline, 3 months, and 6 months.
Depressive Symptoms as assessed by the Hamilton Depression Rating Scale (HRSD-24)
baseline, 3 months, and 6 months
Traditional Chinese Medicine (TCM) Syndrome Score
baseline, 3 months, and 6 months
MRI Examination
baseline, 3 months, and 6 months
- +3 more secondary outcomes
Study Arms (2)
True Electroacupuncture
EXPERIMENTALSham Electroacupuncture
SHAM COMPARATORInterventions
The true electroacupuncture group will receive electroacupuncture treatment for 7 days, once a day, each session lasting approximately 30 minutes. Acupoints include main points (e.g., bilateral forehead lines, Tianzhu BL10, Fengchi GB20) and syndrome-based points. After needle insertion and manual stimulation for deqi, true EA (100 Hz dense wave, tolerable intensity) is applied the SDZ-IIB device, connecting MS2 and BL10 on each side.
The sham electroacupuncture group will receive electroacupuncture treatment for 7 days, once a day, each session lasting approximately 30 minutes.The same acupoints and needle insertion/manual stimulation are used. However, a modified SDZ-IIB device with severed leads (incapable of current output) is connected, simulating the appearance of true electroacupuncture without electrical stimulation. The treatment frequency and duration are identical to the electroacupuncture group.
Eligibility Criteria
You may qualify if:
- Meets diagnostic criteria for Vascular Cognitive Impairment (VCI) per the 2024 Chinese VCI guidelines.
- Meets TCM diagnostic criteria per the 2024 Vascular Mild Cognitive Impairment guidelines.
- Cognitive scores: MMSE 12-24 and MoCA \<24; NIHSS ≤8; AD-8 \<2.
- Age 35-80 years.
- Basic communication ability (Mandarin) and has a stable caregiver.
- Provides written informed consent.
You may not qualify if:
- Severe chronic systemic diseases (e.g., cardiac, hepatic, renal, hematologic) or unstable cardiovascular/cerebrovascular disease.
- Local skin conditions (e.g., herpes, ulceration, keloid) contraindicating acupuncture.
- Contraindications for repeated MRI (e.g., claustrophobia, post-aneurysm embolization).
- Pre-existing cognitive impairment or other major uncontrolled neurological/psychiatric disorders.
- Deemed unsuitable for the study by investigators.
- Participation in another clinical trial within the past 3 months.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 9, 2026
First Posted
February 20, 2026
Study Start
February 10, 2026
Primary Completion (Estimated)
December 31, 2027
Study Completion (Estimated)
December 31, 2027
Last Updated
February 20, 2026
Record last verified: 2025-11